What is ASAP Pharmacy?
Based in Glendale, California, ASAP Pharmacy operates as a critical link in the continuum of end-of-life care. The company distinguishes itself by focusing exclusively on the complex pharmaceutical needs of hospice patients, offering a robust suite of services that includes compounded medications, prescription management, and the provision of durable medical equipment (DME). By maintaining 24/7 availability and a commitment to cost-effective, timely delivery, ASAP Pharmacy addresses the high-acuity requirements of palliative care providers. Their market position is defined by a specialized operational model that integrates seamlessly with hospice workflows, ensuring that patients receive essential support during sensitive periods of care.
How much funding has ASAP Pharmacy raised?
ASAP Pharmacy has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ASAP Pharmacy
PPP
Public-Private Partnership
What's next for ASAP Pharmacy?
With this late-stage financing, ASAP Pharmacy is poised to transition into a phase of accelerated growth and operational optimization. The strategic deployment of this capital will likely focus on enhancing supply chain efficiencies for durable medical equipment and expanding the reach of their specialized compounding services. As the demand for high-quality, hospice-focused pharmaceutical support continues to rise, the company is expected to leverage its current market standing to forge deeper partnerships with regional hospice networks. Future initiatives will likely prioritize technological integration to streamline medication delivery, further cementing their role as an indispensable partner in the palliative care ecosystem.
See full ASAP Pharmacy company page
